Given the onset of DM in DKA positive anti-thyroid thyroxine 1 (DM1), in a patient with phenotypic characteristics of DM2, immunologic markers for diabetes were requested: anti-beta cell antibodies (ICA), anti-glutacid antibodies (IAA),